Luke W. Thomas

1.5k total citations
19 papers, 1.2k citations indexed

About

Luke W. Thomas is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Luke W. Thomas has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Luke W. Thomas's work include Mitochondrial Function and Pathology (11 papers), Cancer, Hypoxia, and Metabolism (11 papers) and RNA modifications and cancer (3 papers). Luke W. Thomas is often cited by papers focused on Mitochondrial Function and Pathology (11 papers), Cancer, Hypoxia, and Metabolism (11 papers) and RNA modifications and cancer (3 papers). Luke W. Thomas collaborates with scholars based in United Kingdom, Switzerland and South Sudan. Luke W. Thomas's co-authors include Steven W. Edwards, Connie W. Lam, Margaret Ashcroft, Robert J. Moots, Andrew Cross, Mathieu Derouet, Ashley King, P. Bischof, Oliver Staples and Mark Turmaine and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Luke W. Thomas

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke W. Thomas United Kingdom 13 814 323 260 205 99 19 1.2k
Meera Nanjundan United States 20 740 0.9× 252 0.8× 213 0.8× 134 0.7× 152 1.5× 35 1.2k
Andrée Yeramian Spain 23 804 1.0× 249 0.8× 318 1.2× 263 1.3× 118 1.2× 51 1.4k
Katarzyna Marta Lisowska Poland 16 736 0.9× 147 0.5× 338 1.3× 295 1.4× 102 1.0× 36 1.3k
Lan Yang China 20 1.0k 1.2× 230 0.7× 435 1.7× 270 1.3× 127 1.3× 57 1.6k
Jianshi Yu United States 20 668 0.8× 176 0.5× 150 0.6× 172 0.8× 86 0.9× 47 1.1k
Sinisa Dovat United States 28 1.0k 1.3× 366 1.1× 216 0.8× 280 1.4× 57 0.6× 105 2.1k
Sabine Heublein Germany 22 543 0.7× 304 0.9× 186 0.7× 277 1.4× 95 1.0× 78 1.3k
Yuji Yaginuma Japan 19 646 0.8× 164 0.5× 208 0.8× 424 2.1× 58 0.6× 51 1.2k
Xiaokui Yang China 21 962 1.2× 270 0.8× 542 2.1× 275 1.3× 67 0.7× 47 1.6k
Manoj Kumar Kashyap United States 23 792 1.0× 161 0.5× 178 0.7× 298 1.5× 171 1.7× 57 1.3k

Countries citing papers authored by Luke W. Thomas

Since Specialization
Citations

This map shows the geographic impact of Luke W. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke W. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke W. Thomas more than expected).

Fields of papers citing papers by Luke W. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke W. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke W. Thomas. The network helps show where Luke W. Thomas may publish in the future.

Co-authorship network of co-authors of Luke W. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Luke W. Thomas. A scholar is included among the top collaborators of Luke W. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke W. Thomas. Luke W. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Thomas, Luke W., et al.. (2024). CHCHD4 regulates the expression of mitochondrial genes that are essential for tumour cell growth. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167282–167282. 1 indexed citations
2.
Thomas, Luke W., Cinzia Esposito, Rachel Morgan, et al.. (2021). Genome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia. Communications Biology. 4(1). 615–615. 14 indexed citations
3.
O’Brien, Katie A., Ben D. McNally, Antonio Murgia, et al.. (2021). Enhanced hepatic respiratory capacity and altered lipid metabolism support metabolic homeostasis during short-term hypoxic stress. BMC Biology. 19(1). 265–265. 7 indexed citations
4.
Thomas, Luke W. & Margaret Ashcroft. (2021). The Contextual Essentiality of Mitochondrial Genes in Cancer. Frontiers in Cell and Developmental Biology. 9. 695351–695351. 3 indexed citations
5.
Thomas, Luke W., Cinzia Esposito, Rachel Morgan, et al.. (2020). Genome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia. Apollo (University of Cambridge). 1 indexed citations
6.
Thomas, Luke W., Cinzia Esposito, Ana S.H. Costa, et al.. (2019). CHCHD4 regulates tumour proliferation and EMT-related phenotypes, through respiratory chain-mediated metabolism. SHILAP Revista de lepidopterología. 7(1). 7–7. 19 indexed citations
7.
Thomas, Luke W. & Margaret Ashcroft. (2019). Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria. Cellular and Molecular Life Sciences. 76(9). 1759–1777. 161 indexed citations
8.
Thomas, Luke W., Cinzia Esposito, Simon Hoer, et al.. (2019). CHCHD4 confers metabolic vulnerabilities to tumour cells through its control of the mitochondrial respiratory chain. SHILAP Revista de lepidopterología. 7(1). 2–2. 17 indexed citations
9.
Briston, Thomas, Luke W. Thomas, Cinzia Esposito, et al.. (2018). VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function. Frontiers in Oncology. 8. 388–388. 21 indexed citations
10.
Habich, Markus, Carmelina Petrungaro, Luke W. Thomas, et al.. (2018). The mitochondrial oxidoreductase CHCHD4 is present in a semi-oxidized state in vivo. Redox Biology. 17. 200–206. 18 indexed citations
11.
Thomas, Luke W., Oliver Staples, Mark Turmaine, & Margaret Ashcroft. (2017). CHCHD4 Regulates Intracellular Oxygenation and Perinuclear Distribution of Mitochondria. Frontiers in Oncology. 7. 71–71. 30 indexed citations
12.
Thomas, Luke W., Connie W. Lam, Richard E. Clark, et al.. (2012). Serine 162, an Essential Residue for the Mitochondrial Localization, Stability and Anti-Apoptotic Function of Mcl-1. PLoS ONE. 7(9). e45088–e45088. 9 indexed citations
13.
Yang, Jun, Oliver Staples, Luke W. Thomas, et al.. (2012). Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression. Journal of Clinical Investigation. 122(2). 600–611. 77 indexed citations
14.
Thomas, Luke W., Connie W. Lam, & Steven W. Edwards. (2010). Mcl‐1; the molecular regulation of protein function. FEBS Letters. 584(14). 2981–2989. 441 indexed citations
15.
Derouet, Mathieu, Luke W. Thomas, Dale Moulding, et al.. (2006). Sodium Salicylate Promotes Neutrophil Apoptosis by Stimulating Caspase-Dependent Turnover of Mcl-1. The Journal of Immunology. 176(2). 957–965. 49 indexed citations
16.
Cross, Andrew, et al.. (2005). Neutrophil gene expression in rheumatoid arthritis. Pathophysiology. 12(3). 191–202. 20 indexed citations
17.
Derouet, Mathieu, Luke W. Thomas, Andrew Cross, Robert J. Moots, & Steven W. Edwards. (2004). Granulocyte Macrophage Colony-stimulating Factor Signaling and Proteasome Inhibition Delay Neutrophil Apoptosis by Increasing the Stability of Mcl-1. Journal of Biological Chemistry. 279(26). 26915–26921. 203 indexed citations
18.
King, Ashley, Luke W. Thomas, & P. Bischof. (2000). Cell Culture Models of Trophoblast II: Trophoblast Cell Lines— A Workshop Report. Placenta. 21. S113–S119. 119 indexed citations
19.
Thomas, Luke W.. (1973). Experimental mycoplasma infections as models of rheumatoid arthritis.. PubMed. 32(2). 143–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meera Nanjundan Breakdown of academic impact, for papers by Andrée Yeramian Breakdown of academic impact, for papers by Katarzyna Marta Lisowska Breakdown of academic impact, for papers by Lan Yang Breakdown of academic impact, for papers by Jianshi Yu Breakdown of academic impact, for papers by Sinisa Dovat Breakdown of academic impact, for papers by Sabine Heublein Breakdown of academic impact, for papers by Yuji Yaginuma Breakdown of academic impact, for papers by Xiaokui Yang Breakdown of academic impact, for papers by Manoj Kumar Kashyap
Rankless by CCL
2026